Allopurinol hypersensitivity syndrome

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Monkbot (talk | contribs) at 18:42, 13 December 2020 (Task 18 (cosmetic): eval 1 template: del empty params (1×);). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Allopurinol hypersensitivity syndrome
Allopurinol

Allopurinol hypersensitivity syndrome typically occurs in persons with preexisting kidney failure.[1]: 119  Weeks to months after allopurinol is begun, the patient develops a morbilliform eruption[1]: 119  or, less commonly, develops one of the far more serious and potentially lethal severe cutaneous adverse reactions viz., the DRESS syndrome, Stevens Johnson syndrome, or toxic epidermal necrolysis.[2]

See also

References

  1. ^ a b James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. ISBN 0-7216-2921-0.
  2. ^ Wang CW, Dao RL, Chung WH (August 2016). "Immunopathogenesis and risk factors for allopurinol severe cutaneous adverse reactions". Current Opinion in Allergy and Clinical Immunology. 16 (4): 339–45. doi:10.1097/ACI.0000000000000286. PMID 27362322.



External links